Elsevier Adaptive Learning for Pharmacology for Nursing Care, 9th Edition
Elsevier Adaptive Learning
Corresponding chapter-by-chapter to Pharmacology for Nursing Care, 9th Edition, Elsevier Adaptive Learning combines the power of brain science with sophisticated, patented Cerego algorithms to help you learn faster and remember longer. It’s fun; it’s engaging; and it’s constantly tracking your performance and adapting to deliver content precisely when it’s needed to ensure core information is transformed into lasting knowledge.
Duration for access to this product, which may be at the discretion of your institution, is up to 36 months. Elsevier reserves the right to restrict or remove access due to changes in product portfolio or other market conditions.
- An individual study schedule reduces cognitive workload and helps you become a more effective learner by automatically guiding the learning and review process.
- The mobile app offers a seamless learning experience between your smartphone and the web with your memory profile maintained and managed in the cloud.
- UNIQUE! Your memory strength is profiled at the course, chapter, and item level to identify personal learning and forgetting patterns.
- UNIQUE! Material is re-presented just before you would naturally forget it to counteract memory decay.
- A personalized learning pathway is established based on your learning profile, memory map, and time required to demonstrate information mastery.
- The comprehensive student dashboard allows you to view your personal learning progress.
I. INTRODUCTION 1. Orientation to Pharmacology 2. Application of Pharmacology in Nursing Practice 3. Drug Regulation, Development, Names, and Information
II. BASIC PRINCIPLES OF PHARMACOLOGY 4. Pharmacokinetics 5. Pharmacodynamics 6. Drug Interactions 7. Adverse Drug Reactions and Medication Errors 8. Individual Variation in Drug Responses
III. DRUG THERAPY ACROSS THE LIFESPAN 9. Drug Therapy During Pregnancy and Breast-Feeding 10. Drug Therapy in Pediatric Patients 11. Drug Therapy in Geriatric Patients IV. PERIPHERAL NERVOUS SYSTEM DRUGS 12. Basic Principles of Neuropharmacology 13. Physiology of the Peripheral Nervous System 14. Muscarinic Agonists and Antagonists 15. Cholinesterase Inhibitors and Their Use in Myasthenia Gravis 16. Drugs That Block Nicotinic Cholinergic Transmission: Neuromuscular Blocking Agents and Ganglionic Blocking Agents 17. Adrenergic Agonists 18. Adrenergic Antagonists 19. Indirect-Acting Antiadrenergic Agents
V. CENTRAL NERVOUS SYSTEM DRUGS 20. Introduction to Central Nervous System Pharmacology 21. Drugs for Parkinson's Disease 22. Alzheimer's Disease 23. Drugs for Multiple Sclerosis 24. Drugs for Epilepsy 25. Drugs for Muscle Spasm and Spasticity 26. Local Anesthetics 27. General Anesthetics 28. Opioid (Narcotic) Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics 29. Pain Management in Patients with Cancer 30. Drugs for Headache 31. Antipsychotic Agents and Their Use in Schizophrenia 32. Antidepressants 33. Drugs for Bipolar Disorder 34. Sedative-Hypnotic Drugs 35. Management of Anxiety Disorders 36. Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder 37. Drug Abuse I: Basic Considerations 38. Drug Abuse II: Alcohol 39. Drug Abuse III: Nicotine and Smoking NEW! 40. Drug Abuse IV: Major Drugs of Abuse Other Than Alcohol and Nicotine
VI: DRUGS THAT AFFECT FLUID AND ELECTROLYTE BALANCE 41. Diuretics 42. Agents Affecting the Volume and Ion Content of Body Fluids
VII: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, AND BLOOD 43. Review of Hemodynamics 44. Drugs Acting on the Renin-Angiotensin-Aldosterone System 45. Calcium Channel Blockers 46. Vasodilators 47. Drugs for Hypertension 48. Drugs for Heart Failure 49. Antidysrhythmic Drugs 50. Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels 51. Drugs for Angina Pectoris 52. Anticoagulant, Antiplatelet, and Thrombolytic Drugs 53. Management of ST-Elevation Myocardial Infarction 54. Drugs for Hemophilia 55. Drugs for Deficiency Anemias 56. Hematopoietic Agents
VIII. DRUGS FOR ENDOCRINE DISORDERS 57. Drugs for Diabetes Mellitus 58. Drugs for Thyroid Disorders 59. Drugs Related to Hypothalamic and Pituitary Function 60. Drugs for Disorders of the Adrenal Cortex
IX. WOMEN'S HEALTH 61. Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 62. Birth Control 63. Drug Therapy of Infertility 64. Drugs That Affect Uterine Function
X. MEN'S HEALTH 65. Androgens 66. Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia
XI. ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC DRUGS 67. Review of the Immune System 68. Childhood Immunization 69. Immunosuppressants 70. Antihistamines 71. Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen 72. Glucocorticoids in Nonendocrine Disorders
XII. DRUGS FOR BONE AND JOINT DISORDERS 73. Drug Therapy of Rheumatoid Arthritis 74. Drug Therapy of Gout 75. Drugs Affecting Calcium Levels and Bone Mineralization
XIII. RESPIRATORY TRACT DRUGS 76. Drugs for Asthma 77. Drugs for Allergic Rhinitis, Cough, and Colds
XIV. GASTROINTESTINAL DRUGS 78. Drugs for Peptic Ulcer Disease 79. Laxatives 80. Other Gastrointestinal Drugs
XV. NUTRITION 81. Vitamins 82. Drugs for Weight Loss
XVI. CHEMOTHERAPY OF INFECTIOUS DISEASES 83. Basic Principles of Antimicrobial Therapy 84. Drugs That Weaken the Bacterial Cell Wall I: Penicillins 85. Drugs That Weaken the Bacterial Cell Wall II: Cephalosporins, Carbapenems, Vancomycin, Telavancin, Aztreonam, Teicoplanin, and Fosfomycin 86. Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others 87. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis 88. Sulfonamides and Trimethoprim 89. Drugs Therapy of Urinary Tract Infections 90. Antimycobacterial Agents: Drugs for Tuberculosis, Leprosy, and Mycobacterium avium Complex Infection 91. Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole, Daptomycin, Rifampin, Rifaximin, Bacitracin, and Polymyxins 92. Antifungal Agents 93. Antiviral Agents I: Drugs for Non-HIV Viral Infections 94. Antiviral Agents II: Drugs for HIV Infection and Related Opportunistic Infections 95. Drug Therapy of Sexually Transmitted Diseases 96. Antiseptics and Disinfectants
XVII. CHEMOTHERAPY OF PARASITIC DISEASES 97. Anthelmintics 98. Antiprotozoal Drugs I: Antimalarial Agents 99. Antiprotozoal Drugs II: Miscellaneous Agents 100. Ectoparasiticides
XVIII. CANCER CHEMOTHERAPY 101. Basic Principles of Cancer Chemotherapy 102. Anticancer Drugs I: Cytotoxic Agents 103. Anticancer Drugs II: Hormonal Agents, Targeted Drugs, and Other Noncytotoxic Anticancer Drugs
XIX. ADDITIONAL IMPORTANT DRUGS 104. Drugs for the Eye 105. Drugs for the Skin 106. Drugs for the Ear 107. Miscellaneous Noteworthy Drugs
XX. ALTERNATIVE THERAPY 108. Dietary Supplements
XXI. TOXICOLOGY 109. Management of Poisoning 110. Potential Weapons of Biologic, Radiologic, and Chemical Terrorism
Jacqueline Burchum, DNSc, APRN, BC, Associate Professor, College of Nursing, Department of Advanced Practice and Doctoral Studies, University of Tennessee Health Science Center, Memphis, Tennessee and Laura Rosenthal, DNP, ACNP, Associate Professor, College of Nursing, University of Colorado Anschutz Medical Campus, Denver, Colorado